Functional Jerks and Twitches: When Does Myoclonus Become an FND Diagnosis?
Sudden jerks, involuntary movements and muscle twitches can arise from numerous neurological and medical conditions. Yet on its NeuroSymptoms website, neurologist Professor Jon Stone describes a category called functional myoclonus, in which jerky movements are attributed to Functional Neurological Disorder (FND). His accompanying January 2014 information sheet acknowledges that myoclonus occurs across a wide range of neurological diseases, while presenting several clinical characteristics as clues to a functional diagnosis.
The difficulty is not recognising that functional jerks have been described in the medical literature. It is establishing when an observed jerk can reliably be attributed to that diagnosis rather than another neurological process. The distinction matters because a movement's appearance, circumstances and response to distraction do not necessarily establish its underlying cause.
When Does a Jerk Become Functional?
NeuroSymptoms lists several features that neurologists may look for when diagnosing functional myoclonus, including sudden onset, jerks involving the trunk, associated facial or vocal movements, trunk flexion while walking, and movements that can be suppressed or delayed through distraction. The website also notes that more than half of patients describe warning sensations before some jerks, occasionally accompanied by tension that temporarily subsides after the movement.
These observations may be clinically relevant, but their diagnostic value depends on how reliably they distinguish functional jerks from other movement disorders. Sudden onset is not exclusive to FND, anatomical distribution does not independently establish a mechanism, and temporary suppression is not unique to functional presentations. Indeed, a 2024 International Federation of Clinical Neurophysiology (IFCN) handbook chapter explicitly acknowledges substantial clinical overlap between functional jerks, neurological myoclonus and tics. Premonitory urges and temporary suppression, for example, can also occur in Tourette syndrome.
This exposes an important distinction between a diagnostic clue and a validated diagnostic discriminator. A characteristic can occur frequently among patients diagnosed with functional myoclonus without being exclusive to that group. The NeuroSymptoms information sheet does not provide sensitivity, specificity or comparative control-group data for its individual clinical features. Consequently, the reader is given examples of what clinicians look for without being shown how much diagnostic certainty those observations justify.
The Medical Causes Already Acknowledged
One particularly revealing aspect of the NeuroSymptoms explanation is its discussion of how functional myoclonus may begin. The website lists physical injuries, medication side effects, fainting episodes, infections and intensive-care admissions among possible preceding events. It also acknowledges the possibility of an underlying mild cause of myoclonus that has supposedly become amplified by an additional functional component.
These are not trivial details. Medication-induced movements, neurological complications following illness and other physiological disturbances are genuine subjects of medical investigation. Their presence in a patient's history should prompt consideration of the relevant medical explanations, rather than automatically serving as evidence for a functional diagnosis. A preceding event may be relevant to symptom onset without establishing what is currently generating the movements.
The proposed amplification model raises a further question. If an underlying medical process is already capable of producing myoclonus, what independent evidence demonstrates that an additional functional mechanism has developed? Greater severity, persistence or variability cannot simply be assumed to establish that second mechanism. Otherwise, the proposed functional contribution risks becoming an explanation for whatever the original medical diagnosis does not adequately account for.
What Does the Brainwave Evidence Actually Show?
NeuroSymptoms describes an electrophysiological investigation called EEG jerk-locked back-averaging, which can detect a brain signal known as the Bereitschaftspotential (BP), or readiness potential, preceding certain movements. The technique combines recordings of brain activity and muscle activation across repeated jerks, allowing researchers to identify electrical activity associated with movement preparation.
Unlike the more general clinical characteristics, this technique has a substantial research literature supporting its diagnostic usefulness in particular comparisons. The 2024 IFCN handbook chapter reports that two studies identified a BP in approximately 47โ86% of patients classified as having functional jerks, compared with none of the patients with neurological myoclonus in those studies. That is meaningful evidence of discriminatory value within the populations examined, and it should not be dismissed.
However, the same review acknowledges that a BP is less specific when functional jerks are compared with neurological tics, and that the test lacks sufficient sensitivity to exclude functional jerks when the signal is absent. The result therefore depends on the clinical comparison being made. A finding that distinguishes two selected diagnostic groups does not necessarily distinguish every possible cause of jerky movements.
There is also a difference between detecting motor preparation and demonstrating the proposed cause of a disorder. The BP is associated with neural activity preceding movement, but its presence does not mean the patient consciously intends, controls or fabricates the movement. The finding can provide evidence relevant to classification without establishing a complete explanation of the mechanism responsible for the symptoms.
Further uncertainty is acknowledged in a Movement Disorders Clinical Practice review examining the diagnostic utility of neurophysiology in jerky movement disorders. Its authors identify problems involving limited patient numbers, inconsistent testing methods and the absence of standardised criteria in parts of the literature. These limitations do not invalidate electrophysiological testing, but they demonstrate why its findings require careful interpretation rather than unquestioning certainty.
Investigating Myoclonus Before Explaining It
Myoclonus is not a single disease. It describes a movement phenomenon that may arise from cortical, subcortical, spinal or peripheral nervous-system processes, among other causes. Determining which process is involved can require more than observing the movement during an ordinary consultation. Surface electromyography (EMG), combined EEG-EMG recordings and other neurophysiological investigations can help characterise muscle activation, identify cortical activity and distinguish between different forms of jerky movement.
A 2023 review on electrophysiological studies of myoclonus emphasises the value of complementing clinical observations with appropriate testing. The 2024 IFCN review similarly identifies electrophysiological findings that support neurological rather than functional myoclonus, including characteristic brief muscle discharges and cortical activity preceding movements. Such investigations are not necessary in every patient, but they become particularly important when the presentation is ambiguous or the differential diagnosis remains substantial.
This creates an obvious problem when diagnostic certainty is expressed without explaining how competing possibilities were evaluated. A clinician may recognise features associated with functional myoclonus, but recognition is not equivalent to demonstrating that other plausible mechanisms have been adequately considered. Nor does the absence of an immediately identifiable structural lesion establish a functional cause.
From Diagnosis to Brain Habits
The NeuroSymptoms factsheet describes persistent functional myoclonus as a habit that the brain has developed. Suggested approaches include distraction, challenging expectations about when jerks will occur, hypnosis and self-hypnosis. It also acknowledges that medication is frequently disappointing and that many patients continue experiencing symptoms despite attempts at treatment.
These suggestions introduce a distinction between a potentially useful treatment strategy and evidence establishing the diagnosis. Distraction may modify a movement without identifying its underlying pathology. Expectations and attention can influence physiological experiences, but demonstrating such an influence does not automatically establish that the original disorder arose through conditioning. Similarly, improvement during hypnosis would not independently prove that the movement was functional.
The factsheet also places considerable emphasis on whether patients have confidence in their diagnosis, suggesting that confidence is important for rehabilitation. Confidence may indeed affect treatment engagement, but it should follow a properly explained diagnostic assessment. Patients questioning the evidence for their diagnosis are not necessarily demonstrating misunderstanding or resistance. They may be asking an entirely reasonable medical question: what findings establish that this particular movement disorder is functional?
The Diagnostic Question Remains
The available literature provides evidence that certain clinical and electrophysiological findings can help distinguish functional jerks from selected neurological movement disorders. It also documents meaningful overlap, imperfect sensitivity and limitations in the reliability and standardisation of testing. Those qualifications are essential when translating research findings into diagnostic decisions involving individual patients.
NeuroSymptoms begins by acknowledging that myoclonus occurs in numerous neurological conditions. That acknowledgement should remain central throughout the diagnostic process. Identifying a jerk, observing that it changes with distraction, or recognising a movement pattern associated with FND does not by itself establish the cause. Where stronger electrophysiological evidence is available, its diagnostic value and limitations should be explained rather than replaced with assumptions about brain habits or conditioned responses.
The question is not whether functional myoclonus exists as a recognised diagnostic category. The question is whether the evidence in an individual case justifies placing a patient within it. If the diagnosis is presented as established, the findings supporting that conclusion should be equally clear. Otherwise, calling the movement functional risks giving an uncertain explanation the appearance of diagnostic certainty.
References
- NeuroSymptoms โ FND Symptoms, including Functional Jerks and Twitches.
- Stone J. (2014). Functional Myoclonus. NeuroSymptoms patient information sheet, January 2014. Supplied source document.
- Edwards MJ et al. (2024). Clinical neurophysiology of functional motor disorders: IFCN Handbook Chapter. Clinical Neurophysiology Practice, 9, 69โ77.
- Diagnostic Utility of Clinical Neurophysiology in Jerky Movement Disorders: A Review from the MDS Clinical Neurophysiology Study Group. Movement Disorders Clinical Practice (2025).
- Vial F, Merchant SHI, McGurrin P, Hallett M. (2023). How to Do an Electrophysiological Study of Myoclonus. Journal of Clinical Neurophysiology, 40(2), 93โ99.